|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [726]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [726]
agement in drug abuse treatment. In J. Grabowski, M. L. Stitzer, & J. E. Henningfield (Eds.) Behavioral intervention techniques in drug abuse treatment (pp. 36–52). Rockville, MD: National Institute on Drug Abuse.
Blaho, K., Merigian, K., Winbery, S., Geraci, S. A., & Smartt, C. (1997). Clinical pharmacology of lysergic acid diethylamide: Case reports and review of the treatment of intoxication. American Journal of Therapeutics, 4, 211–221.
Blum, K., Noble, E. P., Sheridan, P. J., Mongomery, A., Ritchie, T., Jagadeeswaran, P., et al. (1990). Allelic association of human dopamine D2 receptor gene in alcoholism. Journal of the American Medical Association, 263, 2055–2060.
Bolos, A. M., Dean, M., Lucas-Derse, S., Ramsburg, M., Brown, G. L., & Goldman, D. (1990). Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. Journal of the American Medical Association, 264, 3156–3160.
Bonson, K. R., Grant, S. J., Contoreggi, C. S., Links, J. M., Metcalfe, J., Weyl, H. L., et al. (2002). Neural systems and cue-induced cocaine craving. Neuropsychopharmacology, 26, 376–386.
Borduin, C. M., Mann, B. J., Cone, L. T., Henggeler, S. W., Fucci, B. R., Blaske, D. M., et al. (1995). Multisystemic treatment of serious juvenile offenders: Long-term prevention of criminality and violence. Journal of Consulting and Clinical Psychology, 63, 569–578.
Borras, E., Coutelle, C., Rosell, A., Fernandez-Muixi, F., Broch., M., Crosas, B., et al. (2000). Genetic polymorphism of alcohol dehydrogenase in Europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology, 31, 984–989.
Botvin, G. J., Baker, E., Dusenbury, L., Botvin, E. M., & Diaz, T. (1995). Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population. Journal of the American Medical Association, 273, 1106–1112.
Brehm, J. W. (1966). A theory of psychological reactance. New York: Academy Press.
Brehm, S. S., & Brehm, J. W. (1981). Psychological reactance. New York: John Wiley & Sons.
Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee, G. S., Bota, R. G., et al. (2002). Brain metabolic changes during cigarette craving. Archives of General Psychiatry, 59, 1162–1172.
Brown, S. (1993). Recovery patterns in adolescent substance abuse. In J. S. Baer, G. A. Marlott, & M.R.J. (Eds.), Addictive behaviors across the life span: Prevention, treatment, and policy issues (pp. 161–183). Newbury Park, CA: Sage Publications.
Brown, S. A., & D'Amico, E. J. (2003). Outcomes of alcohol treatment for adolescents. Recent Developments in Alcoholism, 16, 289–312.
Buchan, B. J., Dennis, M. L., Tims, F. M., & Diamond, G. S. (2002). Cannabis use: Consistency and validity of self-report, on-site urine testing, and laboratory testing. Addiction, 97 (Suppl. 1), 98–108.
Buchert, R., Obrocki, J., Thomasius, R., Vaterlein, O., Petersen, K., Jenicke, L., et al. (2001). Long-term effects of “ecstasy” abuse on the human brain studied by FDG PET. Nuclear Medicine Communications, 22, 889–897.
Budney, A. J., & Higgins, S. T. (1998). A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Rockville, MD: NIDA.
Budney, A. J., & Moore, B. A. (2002). Development and consequences of cannabis dependence. Journal of Clinical Pharmacology, 42 (11 Suppl), 28S–33S.
Bukstein, O. G., Glancy, L. J., & Kaminer, Y. (1992). Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1041–1045.
Cadoret, R. J., Troughton, E., O'Gorman, T. W., & Heywood, E. (1986). An adoption study of genetic and environmental factors in drug abuse. Archives of General Psychiatry, 43, 1131–1136.
end p.726
|
|
|
|
